TY - JOUR
T1 - Impact of fellowship training on one-year outcomes of robotic-assisted prostatectomy
AU - Thiel, David D.
AU - Hutchinson, Ryan
AU - Diehl, Nancy
AU - Tavlarides, Andrea
AU - Williams, Adrienne
AU - Parker, Alexander S.
PY - 2012/4
Y1 - 2012/4
N2 - Background and Objectives: We examined 1-year functional and oncologic outcomes for robotic-assisted lapa-roscopic prostatectomy (RALP) from a single surgeon entering practice directly from fellowship training. Methods: We prospectively analyzed the first 100 RALPs performed by one fellowship-trained robotic surgeon. Data included resident involvement during the procedure, perioperative data, and surgical complications (scored using the Clavien grading system). Health-related quality of life (HRQOL) data were captured using the EPIC questionnaire at baseline (prior to surgery) and at 1-year follow-up. Results: Eighty-two patients (82%) had hospital stays of 2 days or less without any postoperative complications, ure-thral catheter removal was within 14 days of surgery, and none required readmission to the hospital. The overall positive margin rate was 21% (19% for patients with T2 disease). Clavien grades 1 through 4 complication rates, respectively, were 4%, 10%, 1%, and 1%. There were no deaths, reopera-tions, or bladder neck contractures. One patient (1%) required a blood transfusion within the 90-day perioperative period. At 1-year follow-up, 78% of patients reported wearing no pads; 41.3% of patients with baseline and 1-year follow-up data reported having intercourse. Conclusions: We provide baseline data pertaining to the morbidity, oncologic efficacy, continence results, and potency outcomes of new surgeons performing RALP.
AB - Background and Objectives: We examined 1-year functional and oncologic outcomes for robotic-assisted lapa-roscopic prostatectomy (RALP) from a single surgeon entering practice directly from fellowship training. Methods: We prospectively analyzed the first 100 RALPs performed by one fellowship-trained robotic surgeon. Data included resident involvement during the procedure, perioperative data, and surgical complications (scored using the Clavien grading system). Health-related quality of life (HRQOL) data were captured using the EPIC questionnaire at baseline (prior to surgery) and at 1-year follow-up. Results: Eighty-two patients (82%) had hospital stays of 2 days or less without any postoperative complications, ure-thral catheter removal was within 14 days of surgery, and none required readmission to the hospital. The overall positive margin rate was 21% (19% for patients with T2 disease). Clavien grades 1 through 4 complication rates, respectively, were 4%, 10%, 1%, and 1%. There were no deaths, reopera-tions, or bladder neck contractures. One patient (1%) required a blood transfusion within the 90-day perioperative period. At 1-year follow-up, 78% of patients reported wearing no pads; 41.3% of patients with baseline and 1-year follow-up data reported having intercourse. Conclusions: We provide baseline data pertaining to the morbidity, oncologic efficacy, continence results, and potency outcomes of new surgeons performing RALP.
KW - Prostatectomy
KW - Prostatic neoplasms
KW - Robotics
KW - Training
UR - http://www.scopus.com/inward/record.url?scp=84869837984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84869837984&partnerID=8YFLogxK
U2 - 10.4293/108680812X13291597717220
DO - 10.4293/108680812X13291597717220
M3 - Article
C2 - 23477165
AN - SCOPUS:84869837984
SN - 1086-8089
VL - 16
SP - 195
EP - 201
JO - Journal of the Society of Laparoendoscopic Surgeons
JF - Journal of the Society of Laparoendoscopic Surgeons
IS - 2
ER -